Innocan Pharma Corp. buy Indyro
Start price
15.09.21
/
80%
€0.70
Target price
15.09.22
€2.00
Performance (%)
-41.34%
End price
17.05.22
€0.41
Summary
This prediction ended on 17.05.22 with a price of €0.41. Massive losses of -41.34% were the result for the BUY prediction by Indyro. Indyro has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Innocan Pharma Corp. | - | - | - | - |
| iShares Core DAX® | 2.462% | 4.579% | 23.150% | 68.407% |
| iShares Nasdaq 100 | 1.237% | -0.442% | 7.600% | 114.213% |
| iShares Nikkei 225® | 2.933% | 1.229% | 16.068% | 51.681% |
| iShares S&P 500 | 0.975% | 0.565% | 4.794% | 67.782% |
Comments by Indyro for this prediction
In the thread Innocan Pharma Corp. diskutieren
Buy Innocan Pharma Corp.